Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00367224
Status:
COMPLETED
Last Update Posted:
2024-04-30
First Post:
2006-08-18
Brief Title:
Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
Sponsor:
Henry Ford Health System
Organization:
Henry Ford Health System
Study Overview
Official Title:
Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if vitiligo patients develop tolerance to ultraviolet light therapy a type of treatment available for vitiligo
Detailed Description:
Patients with vitiligo received 6-9 ultraviolet B treatments 2 to 3 times weekly Minimal erythema dose MED testing was done at baseline and after all treatments the percent change in MED was analysed as a measure of photoadaptation The percent decrease in cyclobutane pyrimidine dimers CPDs over 24 hours after a single exposure of 1 MED was analysed on vitiliginous and normal skin
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None